lorazepam has been researched along with framycetin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Herman, RJ; Szakacs, CB; Van Pham, JD | 1 |
| Boctor, MA; Chaudhary, A; Herman, RJ; Lane, R; Szakacs, CB; Woo, D | 1 |
| Chaudhary, A; Herman, RJ; Szakacs, CB | 1 |
1 trial(s) available for lorazepam and framycetin
| Article | Year |
|---|---|
Disposition of lorazepam in Gilbert's syndrome: effects of fasting, feeding, and enterohepatic circulation.
Topics: Adolescent; Adult; Biological Availability; Cholestyramine Resin; Chromatography, High Pressure Liquid; Diet, Fat-Restricted; Drug Interactions; Enterohepatic Circulation; Fasting; Food-Drug Interactions; Gilbert Disease; Glucuronates; Humans; Infusions, Intravenous; Lorazepam; Male; Neomycin | 1994 |
3 other study(ies) available for lorazepam and framycetin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.
Topics: Administration, Oral; Adult; Cholestyramine Resin; Drug Interactions; Enterohepatic Circulation; Humans; Injections, Intravenous; Lorazepam; Male; Neomycin | 1989 |
Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.
Topics: Adolescent; Adult; Cholestyramine Resin; Diabetes Mellitus, Type 1; Humans; Insulin; Lorazepam; Male; Neomycin; Pharmacokinetics | 1995 |